Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

Overview of attention for article published in PharmacoEconomics, July 2018

Altmetric Badge

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 12 Dimensions

Readers on

mendeley: 47 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 21 Jul 2018

#HealthEconJA Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group…